What is Cofoe Medical Technology Co.,Ltd.'s (1187.HK) StockRank?

MoatMap's StockRank for Cofoe Medical Technology Co.,Ltd. (1187.HK) is 90/100, with a Strong Buy signal. This is a composite score combining Quality (68), Value (81), and Momentum (32) factor ranks across MoatMap's 20,000+ stock universe.

Does Cofoe Medical Technology Co.,Ltd. have an economic moat?

Cofoe Medical Technology Co.,Ltd. (1187.HK) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Cofoe Medical Technology Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Cofoe Medical Technology Co.,Ltd. (1187.HK) is Strong Buy, based on a StockRank of 90/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Cofoe Medical Technology Co.,Ltd. in?

Cofoe Medical Technology Co.,Ltd. (1187.HK) operates in the Healthcare sector, specifically the Medical Devices industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

1187.HK

STRONG BUYREMOVE

Cofoe Medical Technology Co.,Ltd. · Healthcare · China · $813M · Avg Vol: $1M/d

StockRank

P/E (TTM)

13.9x

ROE

8.0%

D/E

0.2x

Dividend %

6.0%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Cofoe Medical Technology is a Chinese home medical equipment manufacturer operating in a highly commoditized consumer health space. It lacks pricing power and a durable economic moat, failing the Terry Smith quality compounder lens and showing a weak quant profile.

COMPANY DESCRIPTION

Cofoe Medical Technology Co.,Ltd. researches, develops, manufactures, and sells medical devices and home healthcare equipment, including wheelchairs, blood pressure monitors, and nursing beds. The company's competitive moat is its strong multi-channel sales network, combining a dominant e-commerce presence in China with extensive offline retail coverage. It is a leading player in China's home medical device market, known for its vertically integrated R&D and manufacturing.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	439.9M	421.7M	440.8M	500.6M	4.4%
EPS	—	1.65	1.42	1.75	2.09	8.1%
Shares	—	27.0M	27.0M	27.0M	27.0M	0.0%
Debt	0	68.9M	94.7M	133.5M	122.1M	21.0%
Equity	—	741.9M	724.0M	708.8M	719.2M	-1.0%
Op CF	—	14.6M	58.2M	98.0M	102.8M	91.6%
Inv CF	—	-79.4M	-6.7M	-108.0M	-10.2M	—
Fin CF	—	-19.1M	-41.0M	-34.6M	-69.3M	—

PRICE (1Y)-23.4%

$3.58

RSI (14)

37.1

SCORE BREAKDOWN

Quality

ROIC

8.8%69.6

ROE

8.0%65.8

GP/Assets

33.9%71.5

Op. Margin

13.3%72.0

FCF/Assets

10.4%88.4

Piotroski

892.6

Int. Cover

27.5x72.8

D/E Ratio

0.21x51.0

Current Ratio

2.07x38.5

Value

P/E (TTM)

13.9x77.3

EV/EBITDA

8.3x75.9

P/FCF

9.2x81.2

P/B

1.0x84.2

P/S

1.7x72.2

Div Yield

6.0%94.7

Momentum

52W High %

—N/A

RS 6M

—N/A

SMA 50/200

—N/A

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+27%38.5

Q Growth

17%60.0

FUNDAMENTALS

Market Cap

$813M

P/E (Forward)

10.9x

Gross Margin

53.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1187.HK are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
1187.HK	Cofoe Medical Technology Co.,Ltd.(you)	$813M	90	STRONG BUY
603387.SS	Getein Biotech, Inc	$596M	90	STRONG BUY
2190.HK	Zylox-Tonbridge Medical Technology Co., Ltd.	$768M	84	STRONG BUY
300206.SZ	Edan Instruments, Inc.	$1.1B	91	STRONG BUY
1789.HK	AK Medical Holdings Limited	$729M	96	STRONG BUY
1302.HK	LifeTech Scientific Corporation	$814M	82	STRONG BUY
1763.HK	China Isotope & Radiation Corporation	$767M	82	STRONG BUY
600587.SS	Shinva Medical Instrument Co.,Ltd.	$1.1B	86	STRONG BUY
2172.HK	MicroPort NeuroScientific Corporation	$783M	79	BUY
688016.SS	Shanghai MicroPort Endovascular MedTech Co., Ltd.	$1.6B	91	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.2%

Cofoe Medical Technology Co.,Ltd. (1187.HK) — Stock Score Summary

Cofoe Medical Technology Co.,Ltd. (1187.HK) has a MoatMap StockRank of 90/100 based on Quality (68/100), Value (81/100), and Momentum (32/100) factor scores. The current signal is STRONG BUY. Cofoe Medical Technology is a Chinese home medical equipment manufacturer operating in a highly commoditized consumer health space. It lacks pricing power and a durable economic moat, failing the Terry Smith quality compounder lens and showing a weak quant profile.

Key Financial Metrics

Price	$3.58
Market Cap	$813M
P/E (TTM)	13.91
P/E (Forward)	10.92
Price/Book	0.98
Return on Equity	8.0%
Return on Invested Capital	8.8%
Debt/Equity	21.41
Gross Margin	53.0%
Operating Margin	13.3%
Revenue Growth	37.2%
Dividend Yield	6.0%
Free Cash Flow	$88M

Cofoe Medical Technology Co.,Ltd. operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Cofoe Medical Technology Co.,Ltd.’s (1187.HK) StockRank?: MoatMap’s StockRank for Cofoe Medical Technology Co.,Ltd. (1187.HK) is 90/100, with a Strong Buy signal. It is a composite of Quality (68), Value (81), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does Cofoe Medical Technology Co.,Ltd. have an economic moat?: Cofoe Medical Technology Co.,Ltd. (1187.HK) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cofoe Medical Technology Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Cofoe Medical Technology Co.,Ltd. (1187.HK) is Strong Buy, based on a StockRank of 90/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cofoe Medical Technology Co.,Ltd. in?: Cofoe Medical Technology Co.,Ltd. (1187.HK) operates in the Healthcare sector, specifically the Medical Devices industry (China).